Intellectual Property India Publishes Patent Application for Bispecific Tetravalent Antibody Targeting Her2 And Her3

MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617079902 A) filed by Systimmune, Inc. on June 29, 2026, for Bispecific Tetravalent Antibody Targeting Her2 And Her3.

Inventors include Renshaw, Blair; and Zhu, Yi.

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: Anti-HER2 X HER3 bispecific tetravalent antibodies are configured to have two heavy chains and two light chains and two scFv domains linked to each heavy chain at the N-terminus through a linker, when the Fab region has a binding affinity to HER2 and the scFv domain has a binding affinity to HER3 or vice versa.

Disclaimer: Curated by HT Syndication.